8 patents
Utility
Compounds and Compositions for Treating Conditions Associated with Lpa Receptor Activity
18 Jan 24
Haizhen Zhang, Michael Hanson, Andrew Jennings, Hui Lei, Xichen Lin, Qiong Zhang, Alexandre Cote, Anatoly M. Ruvinsky
Filed: 21 Oct 21
Utility
Heterocyclic GLP-1 Agonists
7 Dec 23
Qinghua MENG, Weiqiang XING, Xichen LIN, Andrew JENNINGS
Filed: 13 Oct 21
Utility
Heterocyclic GLP-1 Agonists
19 Oct 23
Qinghua MENG, Weiqiang XING, Haizhen ZHANG, Xichen LIN, Hui LEI, Andrew JENNINGS
Filed: 8 Sep 21
Utility
Compounds and Compositions for Treating Conditions Associated with Lpa Receptor Activity
12 Oct 23
The present disclosure provides LPA antagonists, as well as pharmaceutical compositions comprising the compounds disclosed herein.
Wei Huang, Hui Lei, Zhongmiao Xu, Haizhen Zhang, Qiong Zhang
Filed: 23 May 23
Utility
Heterocyclic GLP-1 Agonists
12 Oct 23
Qinghua MENG, Weiqiang XING, Haizhen ZHANG, Xichen LIN, Hui LEI, Andrew JENNINGS
Filed: 6 Sep 21
Utility
Heterocyclic GLP-1 Agonists
21 Sep 23
This disclosure relates to GLP-1 agonists of Formula (I): including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
Qinghua MENG, Andrew JENNINGS, Hui LEI, Xichen LIN
Filed: 28 Apr 21
Utility
Compounds and compositions for treating conditions associated with APJ receptor activity
15 Aug 23
This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt and/or hydrate and/or prodrug of the compound) that modulate (e.g., agonize) the apelin receptor (also referred to herein as the APJ receptor; gene symbol “APLNR”).
Haifeng Tang, Sarah Boyce, Michael Hanson, Zhe Nie
Filed: 28 Feb 19
Utility
Heterocyclic GLP-1 Agonists
6 Apr 23
Qinghua MENG, Weiqiang XING, Haizhen ZHANG, Xichen LIN, Hui LEI, Andrew JENNINGS
Filed: 21 Sep 22
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first